Nocardia brain abscesses typically occur in immunocompromised patients. Most cases of nocardiosis are caused by the Nocardia asteroides complex and Nocardia brasiliensis. Here, we present a patient with a Nocardia abscessus brain abscess. The diagnosis was confirmed by DNA sequencing, and the organism was susceptible to linezolid, clarithromycin, ceftriaxone, imipenem, tobramycin, amikacin, minocycline and sulfamethoxazole. The patient was successfully treated medically in combination with surgical excision.
Introduction
Nocardia brain abscess is rare and accounts for 1-2% of all cerebral abscesses [1] . However, brain abscess is the most common secondary infection due to Nocardia. Many cases occur in immunocompromized patients, half of the cases have been reported to have no identifiable risk factors [2] . Most cases of nocardiosis are caused by the N. asteroides complex and N. brasiliensis. The N. asteroides complex includes N. asteroides, N. brasiliensis, N. otitidiscaviarum, N. transvalensis, N. farcinica and N. nova [3] . N. abscessus, previously known as N. asteroides type 1, has been recently reported to cause disease in humans [4] . Thus, N. abscessus data may be buried within this broader designation in earlier studies. Here, we present a case of N. abscessus brain infection in an immunocompetent patient.
Case presentation
The patient was a 37-year-old Saudi gentleman who was admitted with a three-to four-week history of headache, which gradually increased in severity, associated with some dizziness and blurred vision. The patient did not report any fever or chills, and he did not notice any weakness or numbness in the extremities. The patient was initially observed in an outside hospital where he underwent CT and magnetic resonance imaging (MRI), which showed a right occipito-parietal space-occupying lesion with edema that was more compatible with abscess than glioblastoma multiforme. The patient had no history of travel and no significant past medical history. On examination, the patient was afebrile, alert, and oriented to time, place, and person. His lungs were clear to auscultation, and heart sounds were normal. His abdomen was soft and lax and had no tenderness. He had no cranial nerve or motor deficits.
Laboratory data revealed an ESR of 10 mm/h, C-reactive protein 0.5 mg/dl, BUN 17 mg/dl, creatinine 0.9 mg/dl, white blood cell count 15,200/microliter, and hemoglobin 14.4 g/dl. The patient had a normal neutrophil function test, lymphocyte count and normal immunoglobulin levels. He was negative for human immunodeficiency virus.
MRI revealed an intra-axial, the right occipital, 2.3 cm enhancing lesion surrounded by extensive vasogenic edema, with imaging and spectroscopic features most consistent with a brain abscess ( Fig. 1 ). There was a mild adjacent mass effect on the right lateral ventricle, with a preserved vascular flow void. The patient underwent a right occipital craniotomy for gross total resection of the brain lesion using a neuronavigation system. Intra-operatively, there was a hardened vascular capsule containing purulent material. The lesion was resected, and the aspirated material was sent for Gram staining. The stain revealed moderate WBCs, and no organism was identified. Brain tissue showed central acute and chronic inflammation, with reactive changes consistent with an abscess. The patient was started on intravenous vancomycin (500 mg IV q6 hrs), metronidazole (500 mg q8 hrs) and ceftriaxone (2 g q12 hrs) empirically. On the following day, the AFB smear revealed branching filaments resembling Nocardia spp. (Fig. 2) . The organism initially grew in AFB culture, and it was then sent for identification to the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MA, USA. Antibiotics were adjusted to include trimethoprim-sulfamethoxazole (400 mg trimethoprim IV q8 hrs), ceftriaxone (2 g IV q12 hrs) and linezolid (600 mg IV q12 hrs) for 5 weeks. He had an uneventful hospital stay, and he was discharged to continue oral TMP-SMX for an additional 8 weeks. At the time of discharge, the final identification and susceptibility testing became available. He did well with no recurrence one year after the initial presentation. Repeat MRI at that time showed only post-operative changes and parenchymal encephalomalacia of the right occipital lobe with no recurrence.
The cultured organism was identified by DNA sequencing at the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MA, USA. The organism was identified as N. abscessus. Susceptibility testing revealed that the organism was susceptible to linezolid (≤0.25 g/ml), clarithromycin (0.5 g/ml), ceftriaxone (8 g/ml), imipenem (2 g/ml), tobramycin (≤0.25 g/ml), amikacin (≤0.5 g/ml), minocycline (≤1 g/ml) and sulfamethoxazole (≤1 g/ml). The organism was intermediately susceptible to ciprofloxacin (2 g/ml) and amoxicillin-clavulanic acid (16/8 g/ml).
Discussion
Nocardia spp. are aerobic gram-positive bacteria that are ubiquitous in the environment, and infection usually occurs through inhalation or direct cutaneous inoculation of the organism. Systemic infection with Nocardia spp. is frequently observed in immunocompromised hosts and is associated with a high mortality [5] . N. abscessus was characterized in year 2000 after a polyphasic taxonomic analysis of four clinical isolates [6] .
N. abscessus infection is thought to be rare in humans. N. abscessus infection is the cause of 15-18% of nocardiosis cases [7] [8] [9] . In a retrospective study over 7 years (1997-2003) including 27 clinical isolates of Nocardia spp., 6 (22%) were identified as N. abscessus [10] . Only a few cases of N. abscessus infections have been documented in humans: a case of pericarditis [11] , four cases of skin and soft tissue infections [12] , four pulmonary infections, and one patient with a brain abscess [13] . Additional cases of N. abscessus brain abscesses were reported recently and included an HIV-positive patient with disseminated nocardiosis [14] and an N. abscessus brain abscess in two immunocompetent patients [4, 15] . We report an additional case of N. abscessus brain abscess in an immunocompetent patient.
The crude mortality rate was estimated to be higher for N. abscessus and N. farcinica infections (78.5%, relative risk of 3.89) compared to other nocardiosis-causing species [10] ; however, the case in the current report did well with combined medical and surgical therapy. The organism was susceptible to multiple antibiotics, including linezolid, clarithromycin, and sulfamethoxazole. Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice in the treatment of nocardiosis [16] , and the most recent therapeutic alternative is linezolid [17] . In one study, all N. abscessus isolates were susceptible to amikacin, ceftriaxone and linezolid [18] . In conclusion, N. abscessus brain infection may occur in immunocompetent patients. The combination of surgical excision and antimicrobial therapy seems to be associated with a good outcome.
